Sisram Medical Executive and Leadership Team

Eyal David, the Chief Executive Officer & President at Sisram Medical, directs the overarching corporate strategy for the global medical aesthetics portfolio. Overseeing the integration of brands like Alma and Copulla, the Chief Executive Officer & President ensures alignment between technological innovation and market demand. This leadership role involves managing complex relationships with the Board while driving expansion across surgical and beauty markets. By optimizing operational efficiency, Eyal David directly impacts the company's ability to scale hair removal and skin rejuvenation solutions worldwide. The Chief Executive Officer & President maintains a focus on long-term growth, ensuring that the organization remains at the forefront of the wellness industry. Through rigorous oversight of international business units, the Chief Executive Officer & President secures the company's position as a leader in medical aesthetics, consistently delivering value to stakeholders and enhancing the quality of life for millions of consumers.

Tony Chan, the President at Sisram Medical, directs the operational execution of the company's medical aesthetics business model across key international territories. Overseeing the deployment of cutting-edge technologies, the President ensures that clinical solutions reach leading beauty and surgical clinics with maximum efficiency. This leadership role involves managing cross-functional teams to streamline the delivery of hair removal and skin rejuvenation products. By optimizing supply chain logistics and regional distribution, Tony Chan directly impacts the company's revenue growth and market reach. The President collaborates with the executive team to identify emerging opportunities in the medical aesthetics landscape, ensuring that the company remains competitive. Through the oversight of regional performance metrics, the President maintains high standards of service and product reliability. Ultimately, Chan secures the company's operational success by bridging the gap between advanced technological development and the practical needs of clinics worldwide.

Yossi Azulay, the President, Sisram (China) at Sisram Medical, directs the strategic expansion and operational management of the company's medical aesthetics business within the Chinese market. Overseeing the distribution of Alma and Copulla brands, the President, Sisram (China) ensures that local clinics receive the latest innovations in skin rejuvenation and injectables. This leadership role involves navigating complex regulatory environments and building strong partnerships with local medical practitioners. By tailoring the company's global offerings to meet specific regional preferences, Yossi Azulay directly impacts the company's growth in this critical market. The President, Sisram (China) collaborates with the global executive team to align regional objectives with the broader corporate mission. Through the implementation of localized educational programs, the President, Sisram (China) enhances the adoption of advanced aesthetic technologies. Ultimately, Azulay secures a dominant market position by driving consistent revenue growth and clinical excellence throughout the region.

Tal Rosen, the Chief Marketing Officer at Sisram Medical, architects the global brand identity and consumer engagement strategies for the entire medical aesthetics product suite. Overseeing market positioning for Alma and LMNT, the Chief Marketing Officer ensures that clinical messaging resonates with practitioners and end-users alike. This leadership role involves coordinating multi-channel campaigns that highlight the efficacy of injectables and rejuvenation technologies. By analyzing consumer trends, Tal Rosen directly impacts the company's market penetration in key regions. The Chief Marketing Officer collaborates with regional teams to tailor promotional efforts, ensuring consistent brand presence across diverse international clinics. Through the development of educational initiatives, the Chief Marketing Officer strengthens the connection between advanced technology and clinical practice. Ultimately, Rosen drives brand loyalty and market share growth by articulating the unique value proposition of the company's diverse wellness offerings to a global audience.

Orit Segal, the Chief People Officer at Sisram Medical, directs the human capital strategy to support the company's mission of global wellness innovation. Overseeing talent acquisition, organizational development, and corporate culture, the Chief People Officer ensures that the workforce remains aligned with the high standards of the medical aesthetics industry. This leadership role involves implementing training programs that foster expertise in surgical and beauty market technologies. By cultivating a high-performance environment, Orit Segal directly impacts the company's ability to attract top-tier talent across international operations. The Chief People Officer collaborates with executive leadership to refine internal policies, promoting safety and professional growth. Through the management of global HR initiatives, the Chief People Officer secures the organizational stability necessary for sustained innovation. Ultimately, Segal builds the internal infrastructure required to support the company's ambitious growth targets and commitment to excellence in the medical aesthetics sector.